TimeScale Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

TimeScale Financial’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$88.4K	Hold	123	–	–	0.02%	167
2023 Q1	$101K	Hold	123	–	–	0.02%	151
2022 Q4	$84.7K	Hold	123	–	–	0.02%	123
2022 Q3	$85K	Hold	123	–	–	0.02%	123
2022 Q2	$73K	Hold	123	–	–	0.02%	131
2022 Q1	$86K	Hold	123	–	–	0.02%	138
2021 Q4	$78K	Hold	123	–	–	0.02%	148
2021 Q3	$74K	Hold	123	–	–	0.02%	146
2021 Q2	$69K	Hold	123	–	–	0.02%	152
2021 Q1	$58K	Hold	123	–	–	0.02%	166
2020 Q4	$59K	Hold	123	–	–	0.02%	150
2020 Q3	$70K	Hold	123	–	–	0.02%	126
2020 Q2	$77K	Hold	123	–	–	0.02%	111
2020 Q1	$60K	Hold	123	–	–	0.02%	120
2019 Q4	$46K	Hold	123	–	–	0.01%	189
2019 Q3	$34K	Hold	123	–	–	0.01%	215
2019 Q2	$38K	Buy	+123	New	+$40.9K	0.01%	212

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TimeScale Financial's REGN Position: Q2 2023 in Review

TimeScale Financial held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2023 at 123 shares worth $88.4K. The position accounts for 0.02% of the portfolio, ranked #167.

TimeScale Financial first reported a position in REGN in Q2 2019 and has held it in 17 quarters since. The position peaked at $101K in Q1 2023. 1,165 funds tracked by Wall St. Rank hold REGN as of Q2 2023.

TimeScale Financial held 123 shares of Regeneron Pharmaceuticals worth $88.4K as of Q2 2023.
TimeScale Financial left its Regeneron Pharmaceuticals share count unchanged in Q2 2023.
Regeneron Pharmaceuticals made up 0.02% of TimeScale Financial's portfolio in Q2 2023, its #167 holding.
TimeScale Financial first reported a position in Regeneron Pharmaceuticals in Q2 2019 and has held it in 17 quarters since.
TimeScale Financial's Regeneron Pharmaceuticals position peaked at $101K in Q1 2023.
1,165 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.